Loading organizations...
Loading organizations...
Developing molecules to treat cognitive disorders via synaptic modulation.
Syndesi Therapeutics has raised $20.8M across 1 funding round.
Syndesi Therapeutics has raised $20.8M in total across 1 funding round.
Syndesi Therapeutics has raised $20.8M in total across 1 funding round.
Syndesi Therapeutics's investors include Fountain Healthcare Partners, Novo Seeds, Johnson & Johnson Innovation, SRIW, V-Bio Ventures, VIVES Louvain Technology Fund.
Syndesi Therapeutics has raised $20.8M across 1 funding round. Most recently, it raised $20.8M Series A in February 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 9, 2018 | $20.8M Series A | Fountain Healthcare Partners, Novo Seeds | Johnson & Johnson Innovation, SRIW, V-Bio Ventures, VIVES Louvain Technology Fund |